Cardiac regression and blood pressure control in the Dahl Rat treated with either enalapril maleate' (MK 421, an angiotensin converting enzyme inhibitor) or hydrochlorothiazide

Jagdish N. Sharma, Peter G. Fernandez, Bock K. Kim, Halliday Idikio, Christopher Triggle

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Enalapril maleate (MK 421), and hydrochlorothiazide were used to evaluate the control of hypertension and reversal of myocardial hypertrophy in Dahl sensitive (D$) and Dahl resistant (DR) rats given either a high (8% Na GI) or a low salt (0.4% NaCl) diet. Groups of six-week-old male DS and DR rats were treated with enalapril (15-100 mg/kg/day) in drinking water for eight weeks. Additional comparable groups of DS and DR were also treated with hydrochlorothiazide (60-400 mg/kg/day). Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and heart weight/body weight (Hwt/Bwt) ratio were determined. We observed significant reduction in Hwt/Bwt ratio (P <0.001) along with control of SBP and DBP in the DS given a high salt diet treated with either enalapril or hydrochlorothiazide. However, in the DR given a high salt diet, cardiac regression (Hwt/Bwt ratio, P <0.05), SBP and DBP (P <0.01) reduction were seen only with enalapril. Similarly, cardiac regression (Hwt/Bwt ratio, P <0.05) was observed along with reduction of SBP and DBP (P <0.001) in the DS given a low salt diet and DR given enalapril. These data indicate that enalapril reduced SBP and DBP in association with cardiac regression in hypertensive and normotensive rats. In contrast, hydrochlorothiazide only reduced SBP, DBP and caused cardiac reversal (Hwt/Bwt ratio) in DS placed on a high salt diet.

Original languageEnglish
Pages (from-to)251-256
Number of pages6
JournalJournal of Hypertension
Volume1
Issue number3
Publication statusPublished - 1983
Externally publishedYes

Fingerprint

Inbred Dahl Rats
Enalapril
Hydrochlorothiazide
Angiotensin-Converting Enzyme Inhibitors
Blood Pressure
Body Weight
Weights and Measures
Salts
Diet

Keywords

  • Bp control
  • Cardiac hypertrophy
  • Dr
  • Ds
  • Enalapril maleate
  • High salt diets
  • Hydrochlorothiazide
  • Low salt diets
  • Reversal

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Internal Medicine
  • Endocrinology

Cite this

Cardiac regression and blood pressure control in the Dahl Rat treated with either enalapril maleate' (MK 421, an angiotensin converting enzyme inhibitor) or hydrochlorothiazide. / Sharma, Jagdish N.; Fernandez, Peter G.; Kim, Bock K.; Idikio, Halliday; Triggle, Christopher.

In: Journal of Hypertension, Vol. 1, No. 3, 1983, p. 251-256.

Research output: Contribution to journalArticle

@article{0b1f558b73554af7ab0aa3d990de85f9,
title = "Cardiac regression and blood pressure control in the Dahl Rat treated with either enalapril maleate' (MK 421, an angiotensin converting enzyme inhibitor) or hydrochlorothiazide",
abstract = "Enalapril maleate (MK 421), and hydrochlorothiazide were used to evaluate the control of hypertension and reversal of myocardial hypertrophy in Dahl sensitive (D$) and Dahl resistant (DR) rats given either a high (8{\%} Na GI) or a low salt (0.4{\%} NaCl) diet. Groups of six-week-old male DS and DR rats were treated with enalapril (15-100 mg/kg/day) in drinking water for eight weeks. Additional comparable groups of DS and DR were also treated with hydrochlorothiazide (60-400 mg/kg/day). Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and heart weight/body weight (Hwt/Bwt) ratio were determined. We observed significant reduction in Hwt/Bwt ratio (P <0.001) along with control of SBP and DBP in the DS given a high salt diet treated with either enalapril or hydrochlorothiazide. However, in the DR given a high salt diet, cardiac regression (Hwt/Bwt ratio, P <0.05), SBP and DBP (P <0.01) reduction were seen only with enalapril. Similarly, cardiac regression (Hwt/Bwt ratio, P <0.05) was observed along with reduction of SBP and DBP (P <0.001) in the DS given a low salt diet and DR given enalapril. These data indicate that enalapril reduced SBP and DBP in association with cardiac regression in hypertensive and normotensive rats. In contrast, hydrochlorothiazide only reduced SBP, DBP and caused cardiac reversal (Hwt/Bwt ratio) in DS placed on a high salt diet.",
keywords = "Bp control, Cardiac hypertrophy, Dr, Ds, Enalapril maleate, High salt diets, Hydrochlorothiazide, Low salt diets, Reversal",
author = "Sharma, {Jagdish N.} and Fernandez, {Peter G.} and Kim, {Bock K.} and Halliday Idikio and Christopher Triggle",
year = "1983",
language = "English",
volume = "1",
pages = "251--256",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Cardiac regression and blood pressure control in the Dahl Rat treated with either enalapril maleate' (MK 421, an angiotensin converting enzyme inhibitor) or hydrochlorothiazide

AU - Sharma, Jagdish N.

AU - Fernandez, Peter G.

AU - Kim, Bock K.

AU - Idikio, Halliday

AU - Triggle, Christopher

PY - 1983

Y1 - 1983

N2 - Enalapril maleate (MK 421), and hydrochlorothiazide were used to evaluate the control of hypertension and reversal of myocardial hypertrophy in Dahl sensitive (D$) and Dahl resistant (DR) rats given either a high (8% Na GI) or a low salt (0.4% NaCl) diet. Groups of six-week-old male DS and DR rats were treated with enalapril (15-100 mg/kg/day) in drinking water for eight weeks. Additional comparable groups of DS and DR were also treated with hydrochlorothiazide (60-400 mg/kg/day). Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and heart weight/body weight (Hwt/Bwt) ratio were determined. We observed significant reduction in Hwt/Bwt ratio (P <0.001) along with control of SBP and DBP in the DS given a high salt diet treated with either enalapril or hydrochlorothiazide. However, in the DR given a high salt diet, cardiac regression (Hwt/Bwt ratio, P <0.05), SBP and DBP (P <0.01) reduction were seen only with enalapril. Similarly, cardiac regression (Hwt/Bwt ratio, P <0.05) was observed along with reduction of SBP and DBP (P <0.001) in the DS given a low salt diet and DR given enalapril. These data indicate that enalapril reduced SBP and DBP in association with cardiac regression in hypertensive and normotensive rats. In contrast, hydrochlorothiazide only reduced SBP, DBP and caused cardiac reversal (Hwt/Bwt ratio) in DS placed on a high salt diet.

AB - Enalapril maleate (MK 421), and hydrochlorothiazide were used to evaluate the control of hypertension and reversal of myocardial hypertrophy in Dahl sensitive (D$) and Dahl resistant (DR) rats given either a high (8% Na GI) or a low salt (0.4% NaCl) diet. Groups of six-week-old male DS and DR rats were treated with enalapril (15-100 mg/kg/day) in drinking water for eight weeks. Additional comparable groups of DS and DR were also treated with hydrochlorothiazide (60-400 mg/kg/day). Systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR) and heart weight/body weight (Hwt/Bwt) ratio were determined. We observed significant reduction in Hwt/Bwt ratio (P <0.001) along with control of SBP and DBP in the DS given a high salt diet treated with either enalapril or hydrochlorothiazide. However, in the DR given a high salt diet, cardiac regression (Hwt/Bwt ratio, P <0.05), SBP and DBP (P <0.01) reduction were seen only with enalapril. Similarly, cardiac regression (Hwt/Bwt ratio, P <0.05) was observed along with reduction of SBP and DBP (P <0.001) in the DS given a low salt diet and DR given enalapril. These data indicate that enalapril reduced SBP and DBP in association with cardiac regression in hypertensive and normotensive rats. In contrast, hydrochlorothiazide only reduced SBP, DBP and caused cardiac reversal (Hwt/Bwt ratio) in DS placed on a high salt diet.

KW - Bp control

KW - Cardiac hypertrophy

KW - Dr

KW - Ds

KW - Enalapril maleate

KW - High salt diets

KW - Hydrochlorothiazide

KW - Low salt diets

KW - Reversal

UR - http://www.scopus.com/inward/record.url?scp=0021047297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021047297&partnerID=8YFLogxK

M3 - Article

C2 - 6099383

AN - SCOPUS:0021047297

VL - 1

SP - 251

EP - 256

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 3

ER -